SCHEMBL23015657

SCHEMBL23015657

CCc1cc(C(=O)NCCO)ccn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.50
CYP1A2 P05177 1/20 0.50
HPGD P15428 3/20 0.49
HTT P42858 1/20 0.49
KDM4E B2RXH2 4/20 0.46
SMPD1 P17405 1/20 0.45
NEK1 Q96PY6 1/20 0.44
KDM5B Q9UGL1 3/20 0.44
KDM5A P29375 3/20 0.44
KDM5C P41229 2/20 0.44
NAAA Q02083 1/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PRKCI P41743 1/20 0.43
BRD4 O60885 1/20 0.43
ALDH1A1 P00352 2/20 0.42
MAPT P10636 1/20 0.42
THRB P10828 1/20 0.42
ESR2 Q92731 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17920368 0.86 KDM5A (0.55) POLBCYP1A2HTTKDM4EKDM5B
SCHEMBL17689113 0.85 TP53 (0.54) POLBCYP1A2HPGDKDM4EKDM5B
SCHEMBL10357586 0.81 HPGD (0.51) POLBHPGDHTTKDM4ESMPD1
SCHEMBL8945334 0.81 POLB (0.54) POLBHPGDHTTKDM4ENEK1
SCHEMBL16572977 0.81 CYP1A2 (0.56) POLBCYP1A2KDM4EKDM5BKDM5A
SCHEMBL2989555 0.81 CYP1A2 (0.60) POLBCYP1A2HTTKDM4EKDM5B
SCHEMBL15714181 0.81 CYP1A2 (0.49) POLBCYP1A2HTTKDM4EKDM5B
SCHEMBL18369044 0.78 CYP1A2 (0.47) POLBCYP1A2HPGDHTTKDM4E
SCHEMBL3299192 0.78 HPGD (0.51) POLBHPGDHTTKDM4ESMPD1
SCHEMBL17804151 0.78 HPGD (0.59) POLBHPGDHTTKDM4ENEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10927106-B2 Benzothiazole derivatives as DYRK1 inhibitors PHARMASUM THERAPEUTICS AS (NO) 2021-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10927106-B2 Benzothiazole derivatives as DYRK1 inhibitors DYRK1A, DYRK1B, PDK2 POLB 2360/4885CYP1A2 2199/4885HPGD 2051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.